Breath analysis in pulmonary arterial hypertension

Chest

Volumn 145, Issue 3, 2014, Pages 551-558

  Cikach Jr , Frank S ^a   Tonelli, Adriano R ^b   Barnes Dr , Jarrod ^a   Paschke, Kelly ^a   Newman, Jennie ^b   Grove, David ^a   Dababneh, Luma ^a   Wang, Sihe ^a   Dweik, Raed A ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Respiratory Institute   (United States)

^c FCCP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DECENE; 1 OCTENE; 2 NONENE; 2 PROPANOL; ACETALDEHYDE; ALCOHOL; AMMONIA; PENTANE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; BLOOD SAMPLING; BREATH ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICULAR DILATION; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; THERMODILUTION; VALIDATION STUDY; VENOUS OXYGEN TENSION;

ADULT; AIR; BREATH TESTS; CARDIAC CATHETERIZATION; EXHALATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE;

EID: 84896759189     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1363     Document Type: Article

References (42)

1. Badesch DB, Champion HC, Sanchez MA, et al.Diagnosis and assessment of pulmonary arterial hypertension.J Am Coll Cardiol.2009; 54 (suppl 1):S55-S66
2. McLaughlin VV, Archer SL, Badesch DB, et al; ACCF/AHA.ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents andthe American Heart Association: developed in collaborationwith the American College of Chest Physicians, American Thoracic Society, Inc, and the Pulmonary Hypertension Association.Circulation.2009; 119 (16):2250-2294
3. Cracowski JL, Leuchte HH.The potential of biomarkers in pulmonary arterial hypertension.Am J Cardiol.2012; 110 (suppl 6):32S-38S
4. Brown LM, Chen H, Halpern S, et al.Delay in recognition of pulmonary arterial hypertension: factors identifi ed from the REVEAL Registry.Chest.2011; 140 (1):19-26
5. Rich S, Dantzker DR, Ayres SM, et al.Primary pulmonary hypertension. A national prospective study.Ann Intern Med.1987; 107 (2):216-223
6. Howard LS.Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease.Eur Respir Rev.2011; 20 (122):236-242
7. McLaughlin VV, Archer SL, Badesch DB, et al American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association.ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association.J Am Coll Cardiol.2009; 53 (17):1573-1619
8. Benza RL, Gomberg-Maitland M, Miller DP, et al.The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.Chest.2012; 141 (2):354-362
9. Pauling L, Robinson AB, Teranishi R, Cary P.Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography.Proc Natl Acad Sci U S A.1971; 68 (10):2374-2376
10. Dweik RA, Boggs PB, Erzurum SC, et al; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications.An official ATS clinical practice guideline: interpretation of exhaled nitricoxide levels (FENO) for clinical applications.Am J Respir Crit Care Med.2011; 184 (5):602-615
11. Peng NJ, Lai KH, Lo GH, Hsu PI.Comparison of noninvasive diagnostic tests for Helicobacter pylori infection.Med Princ Pract.2009; 18 (1):57-61
12. Machado RF, Londhe Nerkar MV, Dweik RA, et al.Nitric oxide and pulmonary arterial pressures in pulmonary hypertension.Free Radic Biol Med.2004; 37 (7):1010-1017
13. Ozkan M, Dweik RA, Laskowski D, Arroliga AC, Erzurum SC. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.Lung.2001; 179 (4):233-243
14. Kaneko FT, Arroliga AC, Dweik RA, et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension.Am J Respir Crit Care Med.1998; 158 (3):917-923
15. Paschke KM, Mashir A, Dweik RA.Clinical applications of breath testing. F1000 Med Rep.2010; 2:56
16. Barnes PJ, Dweik RA, Gelb AF, et al.Exhaled nitric oxide in pulmonary diseases: a comprehensive review.Chest.2010; 138 (3):682-692
17. Horvath I, Dweik R, Barnes PJ. Exhaled nitric oxide comes of age. J Breath Res; 2012;6(4):040201
18. Grob NM, Dweik RA. Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.J Breath Res.2008; 2 (3):37002
19. Grob NM, Dweik RA.Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet? Chest.2008; 133 (4):837-839
20. Warwick G, Kotylar E, Chow S, et al. Exhaled breath condensate in pulmonary arterial hypertension. J Breath Res.2012;6(3):036006
21. Girgis REC, Champion HC, Diette GB, Johns RA, Permutt S, Sylvester JT.Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy.Am J Respir Crit Care Med.2005; 172 (3):352-357
22. Smith D, Spanel P. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis.Mass Spectrom Rev.2005; 24 (5):661-700
23. Braun PX, Gmachl CF, Dweik RA.Bridging the collaborative gap: realizing the clinical potential of breath analysis for disease diagnosis and monitoring-tutorial.Sensors Journal, IEEE.2012; 12 (11): 3258-3270
24. Cikach FS Jr, Dweik RA.Cardiovascular biomarkers in exhaled breath.Prog Cardiovasc Dis.2012; 55 (1):34-43
25. Mashir A, Dweik RA. Exhaled breath analysis: the new interface between medicine and engineering.Adv Powder Technol.2009; 20 (5):420-425
26. Burns R, Burns R. Discriminatory Analysis. Business Research Methods and Statistics Using SPSS.Thousand Oaks, CA:Sage Publications Ltd; 2009:589-608
27. Hunter GW, Dweik RA. Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications.J Breath Res.2008; 2 (3):037020
28. Machado RF, Laskowski D, Deffenderfer O, et al.Detection of lung cancer by sensor array analyses of exhaled breath.Am J Respir Crit Care Med.2005; 171 (11):1286-1291
29. Mazzone PJ, Hammel J, Dweik R, et al.Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.Thorax.2007; 62 (7):565-568
30. Röck F, Barsan N, Weimar U. Electronic nose: current status and future trends.Chem Rev.2008; 108 (2):705-725
31. Montuschi P, Paris D, Melck D, et al.NMR spectroscopy metabolomic profi ling of exhaled breath condensate in patients with stable and unstable cystic fibrosis.Thorax.2012; 67 (3):222-228
32. Mashir A, Paschke KM, van Duin D, et al. Effect of the infl uenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breath. J Breath Res.2011;5(3):037107
33. Hunter GW, Xu JC, Biaggi-Labiosa AM, et al. Smart sensor systems for human health breath monitoring applications. J Breath Res.2011;5(3):037111
34. Dweik RA.The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity. J Breath Res.2011;5(3):030201
35. de Laurentiis G, Paris D, Melck D, et al.Separating smokingrelated diseases using NMR-based metabolomics of exhaled breath condensate.J Proteome Res.2013; 12 (3):1502-1511
36. Samara MA, Tang WHW, Cikach FS Jr, et al.Single exhaled breath metabolomic analysis identifi es unique breathprint in patients with acute decompensated heart failure.J Am Coll Cardiol.2013; 61 (13):1463-1464
37. Tang WH, Wang Z, Levison BS, et al.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.N Engl J Med.2013; 368 (17):1575-1584
38. Rutter AV, Chippendale TWE, Yang Y, Španěl P, Smith D, Sulé-Suso J.Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.Analyst (Lond).2013; 138 (1):91-95
39. Wu G, Haynes TE, Li H, Yan W, Meininger CJ.Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis.Biochem J.2001; 353 (pt 2):245-252
40. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB.Brick by brick: metabolism and tumor cell growth.Curr Opin Genet Dev.2008; 18 (1):54-61
41. Tonelli AR, Haserodt S, Aytekin M, Dweik RA.Nitric oxide deficiency in pulmonary hypertension: pathobiology and implications for therapy.Pulm Circ.2013; 3 (1):20-30
42. Taylor L, Curthoys NP.Glutamine metabolism: role in acid-base balance*.Biochem Mol Biol Educ.2004; 32 (5):291-304